![]() |
市場調查報告書
商品編碼
1479827
生物反應器市場:產業趨勢和到 2035 年的全球預測 - 依製造材料、生物製程、生物產品、關鍵地區劃分Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication Material, Type of Bioprocess, Type of Biologic, and Key Geographical Regions |
生物反應器市場規模預計到 2024 年將達到 167 億美元,並預計在 2024-2035 年預測期內複合年增長率為 11.1%。
生物反應器是一種用於上游生物製造的專用容器,可在精確控制的條件下促進細胞和組織的生長。 這些條件包括溫度、pH、壓力、通氣和營養水平等因素,旨在優化活細胞和細胞組成的環境。 主要目標是促進底物轉化為多種生物產品。 這些產品範圍從疫苗、融合蛋白、抗體、激素、白細胞介素和□等治療蛋白到基於細胞和寡核甘酸的治療藥物、用於基因治療的逆轉錄病毒載體,以及模仿3D 組織結構的2D和先進體外模型。 一般來說,這些生物反應器是圓柱形的,通常由不銹鋼製成,尺寸從毫升到幾公升不等,適合不同的生物過程需求和操作模式。
全球對生物製藥的需求迅速成長,大大推動了生物製程用品市場的成長。 隨著公司建立自己的生物製藥生產設施或將生產外包給專業機構,對臨床和商業規模生物反應器的需求正在迅速增加。 目前估計全球生物反應器產能超過 1,300 萬公升,包括內部生產和外包生產。 由於這種巨大的需求,生物反應器市場已發展成為一個競爭激烈的舞台,許多活躍的公司在設計、工程和製造各種應用的生物反應器方面擁有專業知識。 我們提供的產品範圍從傳統的不銹鋼生物反應器到一次性/一次性生物反應器、攪拌罐生物反應器、小型生物反應器、氣升式生物反應器、灌註生物反應器、泡罩塔生物反應器和光生物反應器。
本報告調查了全球生物反應器市場,並概述了市場概況、製造材料、生物工藝、生物產品、地區以及進入市場的公司概況。
Bioreactors Market: Industry Trends and Global Forecasts, till 2035 - Distribution by Fabrication Material (Glass, Stainless Steel and Single use), Type of Bioprocess (Batch, Fed-batch and Continuous), Type of Biologic (Antibodies, Vaccines, Cell Therapies and Other Biologics), and Key Geographical Regions (North America, Europe, Asia-Pacific, and Rest of the World)
The Bioreactors Market is valued at USD 16.7 billion in 2024 growing at a CAGR of 11.1% during the forecast period 2024-2035.
Bioreactors represent specialized vessels employed in upstream biomanufacturing to foster the growth of cells and tissues under precisely controlled conditions. These conditions encompass factors like temperature, pH, pressure, aeration, and nutrient levels, all aimed at optimizing the environment for live cells or cellular components. The primary goal is to facilitate the conversion of substrates into a diverse array of biological products. These products span from therapeutic proteins such as vaccines, fusion proteins, antibodies, hormones, interleukins, and enzymes to cutting-edge medicinal products like cell-based and oligonucleotide-based therapies, retroviral vectors for gene therapy, and sophisticated in vitro models mimicking 2D and 3D tissue constructs, essential for drug discovery research. Typically, these bioreactors, often cylindrical and made of stainless steel, vary in size from milliliters to several liters, tailored to different bioprocessing needs and operational modes.
The surge in global demand for biopharmaceutical products has significantly propelled the growth of the bioprocessing supplies market. As companies either establish their own biopharmaceutical manufacturing facilities or opt to outsource production to specialized organizations, the demand for clinical and commercial-scale bioreactors has skyrocketed. Current estimates, including both in-house and outsourced capacities, indicate a global bioreactors capacity exceeding 13 million liters. Given this immense demand, the bioreactors market has evolved into a competitive arena, featuring numerous active companies boasting expertise in designing, engineering, and manufacturing a wide spectrum of bioreactors tailored to diverse applications. Offerings range from traditional stainless-steel bioreactors to disposable/single-use bioreactors, stirred-tank bioreactors, small-scale bioreactors, air lift bioreactors, perfusion bioreactors, bubble column bioreactors, and photobioreactors.
Key Market Segments
Fabrication Material
Stainless Steel
Single Use
Glass
Type of Bioprocess
Batch and Fed-batch
Continuous
Type of Biologic
Antibodies
Vaccines
Cell Therapies
Other Biologics
Key Geographical Regions
North America
Europe
Asia-Pacific
Rest of the World
Research Coverage:
A comprehensive analysis of the overall market landscape of companies manufacturing bioreactors, based on several relevant parameters, such as year of establishment, company size (in terms of number of employees), region of headquarters, geographical reach (North America, Europe, Asia-Pacific and Rest of the World), capacity (micro-mini, small-scale, bench-scale, lab-scale, pilot-scale and large-scale), scale of operation (preclinical, clinical and commercial), scalability, type of bioprocess (batch, fed-batch and continuous), type of cell culture (2D cell culture, 3D cell culture and 4D cell culture), mode of operation (manual, semi-automatic and automatic) and type of end user (academic institutes and research laboratories, biopharmaceutical and pharmaceutical industries, contract manufacturing organizations, and contract research organizations).
Comprehensives company competitiveness analysis of bioreactor manufacturers based on manufacturer strength (in terms of years of experience and company size), portfolio strength (considering geographical reach, number of products in portfolio, type of bioreactor, capacity, scale of operation, scalability, type of bioprocess, type of cell culture, mode of operation and end users).
Comprehensive company profiles of leading players manufacturing bioreactors (shortlisted on the basis of cumulative strength of manufacturers and product portfolio); each profile includes a brief overview of the company, along with information on its financial information (if available), product portfolio, recent developments and an informed future outlook.
A projection of the global installed capacity of bioreactors for biologics, compiled from data sourced from various publicly available industry outlets. This estimation also includes a breakdown of the available capacity categorized by fabrication material (glass, stainless steel, and single-use), cell culture source (mammalian, microbial, and others), reactor volume (less than 2,000 L, 2,000 to 5,000 L, 5,001 to 10,000 L, and over 10,000 L), manufacturer type (in-house, hybrid, and Contract Manufacturing Organizations [CMOs]), and major geographical regions (North America, Europe, Asia-Pacific, and Rest of the World).
A case study on the market landscape of bioprocess controllers and automation systems, providing information on scale of operation (laboratory, clinical, and commercial), key features (scalability / ease to use, visual data display, remote accessibility, built-in system control sensors, expansive I/O compatibility and provisions for alarms / alerts), compatibility with bioreactor system (stirred tank (glass), single use bioreactor, stirred tank (steel), rocking motion), type of bioprocess (batch, fed-batch and perfusion), and type of process controlled (cell cultivation and microbial fermentation). In addition, the chapter presents details of companies involved in the development of bioprocess control software, upstream and downstream controllers, including information on their year of establishment, company size, and location of headquarters.
A comprehensive market forecast analysis has been conducted to assess the current market size and future prospects for the bioreactors market over the coming 11 years. Utilizing multiple parameters and anticipated adoption trends, coupled with primary validations, we have developed informed estimates for market size within the forecast period spanning from 2024 to 2035. This chapter presents detailed projections of both current and future opportunities within the market, segmented across various factors including fabrication material (glass, stainless steel, and single-use), bioprocess type (batch, fed-batch, and continuous), types of biologics (such as antibodies, vaccines, cell therapies, and other biologics), and key geographical regions (North America, Europe, Asia-Pacific, and Rest of the World).
Key Benefits of Buying this Report
The report offers market leaders and newcomers valuable insights into revenue estimations for both the overall market and its sub-segments.
Stakeholders can utilize the report to enhance their understanding of the competitive landscape, allowing for improved business positioning and more effective go-to-market strategies.
The report provides stakeholders with a pulse on the Bioreactors Market, furnishing them with essential information on significant market drivers, barriers, opportunities, and challenges.
Leading Market Companies
Applikon Biotechnology
Bionet
Cytiva
Eppendorf
Merck
Ollital Technology
Parr Instrument Company
Sartorius
Shanghai Bailun Biological Technology
Solaris Biotech
Solida Biotech
Zhengzhou Laboao Instrument Equipment (LABAO)